CHICAGO (Reuters) - Medtronic Inc said on Tuesday it received regulatory approval in Europe for an implantable brain stimulator to treat patients with severe obsessive-compulsive disorder.div class="feedflare"
a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=jbBUqVTva7w:qw9TGA8YFz8:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=jbBUqVTva7w:qw9TGA8YFz8:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=jbBUqVTva7w:qw9TGA8YFz8:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=jbBUqVTva7w:qw9TGA8YFz8:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=jbBUqVTva7w:qw9TGA8YFz8:V_sGLiPBpWU" border="0"/img/a
/divimg src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/jbBUqVTva7w" height="1" width="1"/